… that stimulate large numbers of T cells expressing particular T-cell receptor Vβ elements. …
molecular variants probably stimulate a similar subset of T cells to SEQ and SEK because of the …

Recent advancements in stem cell technology open a new door for patients suffering from
diseases and disorders that have yet to be treated. Stem cell-based therapy, including human …

Stroke is the second leading cause of death and the third leading cause of disability worldwide
and its burden is increasing rapidly in low-income and middle-income countries, many of …

Background Trials of endovascular therapy for ischemic stroke have produced variable
results. We conducted this study to test whether more advanced imaging selection, recently …

On board the four Cluster spacecraft, the Cluster Ion Spectrometry (CIS) experiment measures
the full, three-dimensional ion distribution of the major magnetospheric ions (H + , He + , …

Stem cells, which are clonogenic cells with self-renewal and multilineage differentiation
properties, have the potential to replace or repair damaged tissue. We have directly isolated …

The current design requirement for a tissue engineering skin substitute is that of a biodegradable
scaffold through which fibroblasts can migrate and populate. This artificial “dermal layer…

… We fix r and t 0 , as it is not possible to uniquely identify r, t 0 and β m i n from death or case
… two states, and for the two choices of β ( t ) . Note that while modeled and actual cumulative …

… All MRI studies were obtained with a 1.5-T echoplanar image equipped whole-body scanner
(Signa Horizon SR 120, General Electric). Acute and subacute sequences consisted of a T1…

Background The time to initiate intravenous thrombolysis for acute ischemic stroke is generally
limited to within 4.5 hours after the onset of symptoms. Some trials have suggested that …